[ Price : $8.95]
Industry commenters call on FDA to provide NDA-type pre-submission communication opportunities to generic sponsors and include add...[ Price : $8.95]
FDA contracts with MasterControl Inc. to expand its quality management software solutions and services in the agencys Office of Re...[ Price : $8.95]
FDA approves a Par Pharmaceutical NDA for Vasostrict (vasopressin injection) 20 units/mL, indicated for increasing blood pressure ...[ Price : $8.95]
Reuters reports that Indian drug industry executives say a continuing FDA backlog of generic drug approvals is hurting their U.S. ...[ Price : $8.95]
AstraZeneca and Amgen say their investigational psoriasis drug brodalumab topped Janssens Stelara in a head-to-head Phase 3 trial....[ Price : $8.95]
Attorneys Jamie Wolszon and Jeffrey Gibbs say FDAer Alberto Gutierrez answered some industry questions about the agencys draft gui...[ Price : $8.95]
FDA funds research at the UKs University of Bath to help lower the cost of drugs.[ Price : $8.95]
FDA grants Xeris Pharmaceuticals an orphan drug designation for its soluble glucagon, an investigational drug for preventing sever...